LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT – Abbott Laboratories Transaction History
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT portfolio value:
$4.12M
portfolio value
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -28.75% | -17.2K shares | -2.37M | $96.76 | 42.61K |
Q2 2022 | share | Decrease | -9.39% | -6.2K shares | -1.31M | $108.65 | 59.81K |
Q1 2022 | share | Increase | +2.01% | 1.3K shares | -1.29M | $118.36 | 66.01K |
Q4 2021 | share | Decrease | -10.14% | -7.3K shares | 601K | $141 | 64.71K |
Q3 2021 | share | Decrease | -6.85% | -5.3K shares | -458K | $117.68 | 72.01K |
Q2 2021 | share | Increase | +8.41% | 6K shares | 417K | $115.05 | 77.31K |
Q1 2021 | share | Increase | +11.06% | 7.1K shares | 1.51M | $118.49 | 71.31K |
Q4 2020 | share | Increase | +16.93% | 9.3K shares | 1.05M | $107.81 | 64.21K |
Q3 2020 | share | Increase | +37.23% | 14.9K shares | 2.31M | $106.81 | 54.91K |
Q2 2020 | share | Increase | +2.30% | 900 shares | 572K | $89.39 | 40.01K |
Q1 2020 | share | Increase | +15.67% | 5.3K shares | 150K | $76.84 | 39.11K |
Q4 2019 | share | Decrease | -11.05% | -4.2K shares | -244K | $84.23 | 33.81K |
Q3 2019 | share | Increase | +6.74% | 2.4K shares | 185K | $80.81 | 38.01K |
Q2 2019 | share | Increase | +11.24% | 3.6K shares | 437K | $80.92 | 35.61K |
Q1 2019 | share | Increase | +21.20% | 5.6K shares | 648K | $76.6 | 32.01K |
Q4 2018 | share | 0.00% | 0 shares | -27K | $68.98 | 26.41K | |
Q3 2018 | share | Decrease | -20.71% | -6.9K shares | -94K | $69.69 | 26.41K |
Q2 2018 | share | Decrease | -11.67% | -4.4K shares | -228K | $57.68 | 33.31K |
Q1 2018 | share | Decrease | -13.53% | -5.9K shares | -229K | $56.4 | 37.71K |
Q4 2017 | share | Decrease | -28.04% | -17K shares | -745K | $53.46 | 43.61K |
Q3 2017 | share | Decrease | -11.92% | -8.2K shares | -111K | $49.74 | 60.61K |
Q2 2017 | share | 0.00% | 0 shares | 289K | $45.07 | 68.81K | |
Q1 2017 | share | Decrease | -44.47% | -55.1K shares | -1.70M | $40.93 | 68.81K |
Q4 2016 | share | Increase | +154.24% | 75.17K shares | -3.82M | $35.17 | 123.91K |
Q3 2016 | share | Decrease | -70.37% | -115.77K shares | 2.12M | $38.48 | 48.74K |
Q2 2016 | share | 0.00% | 0 shares | -415K | $35.55 | 164.51K | |
Q1 2016 | share | 0.00% | 0 shares | -507K | $37.6 | 164.51K |